Epilepsy Seizure Articles & Analysis
6 news found
“About a third of individuals with epilepsy have drug-resistant seizures. Removal or ablation of the affected temporal lobe can be an option, but many people with epilepsy are not eligible or interested in a tissue-destructive procedure. ...
These algorithms can be focused on therapeutic areas such as neurodegenerative disorders, epilepsy, sleep disorders and mental illness. For example, Beacon is currently assessing novel EEG signatures in Alzheimer's disease patients to identify which patients may or may not benefit from a specific type of therapy. ...
The company’s beachhead product, available in Europe, Australia and New Zealand, is for people with absence epilepsy, the most common pediatric epilepsy syndrome causing absence seizures, which mostly look like daydreaming. Yet for the person themselves an absence seizure is a full blackout with no recollection of what ...
For the August installment of the Healthtech Leader of the Month series, we interviewed Aswin Gunasekar, founder and CEO of Zeto. Zeto is a device-driven platform for acquiring, accessing, and interpreting electroencephalograms (EEGs). An EEG is a test used to evaluate electrical activity in the ...
The prevalence of sleep disorders, epilepsy and cardiovascular disease pose a significant challenge to the US healthcare system. Notably, 70 million Americans suffer from some form of a sleep disorder, 1 in 26 people will develop epilepsy or recurrent seizures during their lifetime, and 48% of all adults in the US have some type of cardiovascular ...
Belgian health tech startup epihunter NV is awarded a $200,000 grant from Epilepsy Foundation to further validate and market their CE labelled epileptic seizure detection algorithm. ...